Name: Relias Media
Price range: $

The Photosensitive Patient

Photosensitivity is an abnormal cutaneous reaction to visible or ultraviolet light. The photodermatoses often overlap clinically, and a broad understanding may help facilitate proper diagnosis, treatment, and/or referral. This article will address several of the different photodermatoses and their clinical entities, and will provide a guide for evaluation of the photosensitive patient.

Pharmacology Watch

The JUPITER trial causes a stir; ACP practice guideline for antidepressant use; testosterone for low libido; continued shortage of Hib vaccine; FDA Actions.

Hypertension Update

Hypertension is one of the most common conditions that primary care physicians face on a daily basis in the office. Control of hypertension is one of the most important therapeutic actions that the physician can do to prevent the development of serious complications in his or her patients.

Clinical Briefs in Primary Care Supplement

Pharmacology Watch

5-α reductase inhibitors and hip fracture in men; the effects of drug-reimbursement policy on outcomes; new guidelines for type 2 diabetes; beta-blocker-associated brady-cardia is linked to CVD events; FDA Updates.

Clinical Briefs in Primary Care Supplement

Soft-Tissue Rheumatism: Diagnosis and Management

Soft-tissue rheumatism often is a challenging disorder for the primary care physicians. The patient's symptoms often are vague, and the physical examination and laboratory testing often do not give comforting confirmatory findings. This issue reviews common conditions that afflict many of our patients and that, although often not serious, cause significant distress and morbidity. With the proper history and attention to presenting features, effective and professionally rewarding treatments are available.

Pharmacology Watch

Ongoing safety review of tiotropium; raloxifene reduces the risk of endometrial cancer; one-day treatment with famciclovir may be as effective as 3-day treatment with valacyclovir; new Clinical Practice Guideline from the American College of Physicians regarding pharmacologic treatment for low bone density and osteoporosis; FDA Actions.